MetLife Analysts Recommendations and Consensus

MET -- USA Stock  

USD 43.96  0.84  1.88%

The current analyst and expert consensus on MetLife is Buy with 0 strong sell and 6 strong buy opinions. The current projected target price consensus is 55.88 with 8 analysts opinions. The most common way MetLife analysists use to provide recommendation to public is financial statements analysis. Many experts also interview MetLife executives and customers to further validate their buy or sell advice. MetLife buy or sell recommendation module provides average expert sentiment on the projected MetLife target price to derive its highest and lowest estimates based on projected price volatility of 6.49. Please see also Macroaxis Advice on MetLife to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

MetLife Target Price Consensus

Number of Opinions11
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

MetLife Target Price Projection

Current Price

MetLife Market Quote

Low Price43.82Odds
High Price44.7Odds

43.96

Target Price

Analyst Consensus On Target Price

Low Estimate44.0Odds
High Estimate62.0Odds
Number of Analysts8
Standard Deviation6.49

55.875

MetLife Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Artificial Intelligence
Purchased over 20 shares
Traded a day ago for 107.27
Driverless Cars
Purchased over 70 shares
Traded a day ago for 35.345
Artificial Intelligence
Purchased over 20 shares
Traded a day ago for 131.79
Artificial Intelligence
Purchased over 20 shares
Traded a day ago for 144.05
Baby Boomer Prospects
Purchased over 40 shares
Traded a day ago for 64.52
Baby Boomer Prospects
Purchased over 40 shares
Traded a day ago for 64.52
Please see also Macroaxis Advice on MetLife to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Search macroaxis.com